Although this signaling complex has not been investigated in cancer, Nectin-4 enhancement of HER2 signaling has been investigated in relation to tyrosine kinase inhibitor-resistance in breast cancer [305]. This evidence concerns the gene ERBB2 and breast carcinoma.